Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2021

15.09.2020 | Review

Width of margins in phyllodes tumors of the breast: the controversy drags on?—a systematic review and meta-analysis

verfasst von: Arnaud Toussaint, Romain Piaget-Rossel, Coraline Stormacq, Patrice Mathevet, Karine Lepigeon, Patrick Taffé

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Phyllodes tumors (PT) of the breast are rare fibroepithelial neoplasms. Information is controversial in the literature regarding to the optimal surgical management. Most studies suggested margins of at least 10 mm while some recent studies suggested narrower margins without an increased risk of local recurrences (LR) and distant metastases (DM). The objective of this systematic review was to identify and compare studies that assessed these different practices.

Methods

A systematic review was performed through five databases up to April 2019. Studies exploring the association between the width of margins, subtypes of PT, and the LR and DM rates were considered for inclusion. A statistical model for analyzing sparse data and rare events was used.

Results

Thirteen studies met eligibility criteria and were selected. Considering a threshold of 10 mm (margins < 10 vs margins ≥ 10 mm), the 5-year incidence rate of LR was estimated to be 5.22 vs. 3.63 (diff. −1.59) per 100 person-years for benign PT, 9.60 vs. 7.33 (diff. −2.27) for borderline PT, and 28.58 vs. 21.84 (diff. −6.74) for malignant PT. For DM, it was estimated to be 0.88 vs. 0.86 (diff. −0.02) for benign PT, 1.61 vs. 1.74 (diff. 0.13) for borderline PT, and 4.80 vs 5.18 (diff. 0.38) for malignant PT. The data for a threshold of 1 mm were not sufficient to draw any conclusions.

Conclusion

Irrespective of tumor grade, we found that DM was a rarer event than LR. Malignant PT had the highest incidence rate of LR and DM. This meta-analysis found a clear association between width of margins and LR rates. Whatever the tumor grade, surgical margins ≥ 10 mm guaranteed a lower risk of LR than margins < 10 mm. On the other hand, the width of margin did not influence the apparition of DM.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Guillot E, Couturaud B, Reyal F, Curnier A, Ravinet J, Laé M et al (2011) Management of Phyllodes Breast Tumors. Breast J 17:129–137PubMed Guillot E, Couturaud B, Reyal F, Curnier A, Ravinet J, Laé M et al (2011) Management of Phyllodes Breast Tumors. Breast J 17:129–137PubMed
2.
Zurück zum Zitat The World Health Organization. The World Health Organization Histological Typing of Breast Tumors–Second Edition. The World Organization. Am J Clin Pathol 1982;78:806–16. The World Health Organization. The World Health Organization Histological Typing of Breast Tumors–Second Edition. The World Organization. Am J Clin Pathol 1982;78:806–16.
3.
Zurück zum Zitat Khosravi-Shahi P (2011) Management of non metastatic phyllodes tumors of the breast: Review of the literature. Surg Oncol 20:e143–e148PubMed Khosravi-Shahi P (2011) Management of non metastatic phyllodes tumors of the breast: Review of the literature. Surg Oncol 20:e143–e148PubMed
4.
Zurück zum Zitat Kim S, Kim JY, Kim DH, Jung WH, Koo JS (2013) Analysis of phyllodes tumor recurrence according to the histologic grade. Breast Cancer Res Treat 141:353–363PubMed Kim S, Kim JY, Kim DH, Jung WH, Koo JS (2013) Analysis of phyllodes tumor recurrence according to the histologic grade. Breast Cancer Res Treat 141:353–363PubMed
5.
Zurück zum Zitat Ramakant P, Chakravarthy S, Cherian JA, Abraham DT, Paul MJ (2013) Challenges in management of phyllodes tumors of the breast: A retrospective analysis of 150 patients. Indian J Cancer 50(4):345–348PubMed Ramakant P, Chakravarthy S, Cherian JA, Abraham DT, Paul MJ (2013) Challenges in management of phyllodes tumors of the breast: A retrospective analysis of 150 patients. Indian J Cancer 50(4):345–348PubMed
6.
Zurück zum Zitat Ben Hassouna J, Damak T, Gamoudi A, Chargui R, Khomsi F, Mahjoub S et al (2006) Phyllodes tumors of the breast: a case series of 106 patients. Am J Surg 192:141–147PubMed Ben Hassouna J, Damak T, Gamoudi A, Chargui R, Khomsi F, Mahjoub S et al (2006) Phyllodes tumors of the breast: a case series of 106 patients. Am J Surg 192:141–147PubMed
7.
Zurück zum Zitat Tan PH, Jayabaskar T, Chuah KL, Lee HY, Tan Y, Hilmy M et al (2005) Phyllodes tumors of the breast: the role of pathologic parameters. Am J Clin Pathol 123:529–540PubMed Tan PH, Jayabaskar T, Chuah KL, Lee HY, Tan Y, Hilmy M et al (2005) Phyllodes tumors of the breast: the role of pathologic parameters. Am J Clin Pathol 123:529–540PubMed
8.
Zurück zum Zitat Wei J, Tan YT, Cai YC, Yuan ZY, Yang D, Wang SS et al (2014) Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single center. Chin J Cancer 33:492–500PubMedPubMedCentral Wei J, Tan YT, Cai YC, Yuan ZY, Yang D, Wang SS et al (2014) Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single center. Chin J Cancer 33:492–500PubMedPubMedCentral
9.
Zurück zum Zitat Borhani-Khomani K, Talman ML, Kroman N, Tvedskov TF (2016) Risk of Local Recurrence of Benign and Borderline Phyllodes Tumors: A Danish Population-Based Retrospective Study. Ann Surg Oncol 23:1543–1548PubMed Borhani-Khomani K, Talman ML, Kroman N, Tvedskov TF (2016) Risk of Local Recurrence of Benign and Borderline Phyllodes Tumors: A Danish Population-Based Retrospective Study. Ann Surg Oncol 23:1543–1548PubMed
10.
Zurück zum Zitat Barth RJ Jr (1999) Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res Treat 57:291–295PubMed Barth RJ Jr (1999) Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res Treat 57:291–295PubMed
11.
Zurück zum Zitat Asoglu O, Ugurlu MM, Blanchard K, Grant CS, Reynolds C, Cha SS et al (2004) Risk factors for recurrence and death after primary surgical treatment of malignant phyllodes tumors. Ann Surg Oncol 11:1011–1017PubMed Asoglu O, Ugurlu MM, Blanchard K, Grant CS, Reynolds C, Cha SS et al (2004) Risk factors for recurrence and death after primary surgical treatment of malignant phyllodes tumors. Ann Surg Oncol 11:1011–1017PubMed
12.
Zurück zum Zitat Reinfuss M, Mitus J, Duda K, Stelmach A, Rys J, Smolak K (1996) The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer 77:910–916PubMed Reinfuss M, Mitus J, Duda K, Stelmach A, Rys J, Smolak K (1996) The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer 77:910–916PubMed
13.
Zurück zum Zitat Rowell MD, Perry RR, Hsiu J-G, Barranco SC (1993) Phyllodes tumors. Am J Surg 165:376–379PubMed Rowell MD, Perry RR, Hsiu J-G, Barranco SC (1993) Phyllodes tumors. Am J Surg 165:376–379PubMed
14.
Zurück zum Zitat Mangi AA, Smith BL, Gadd MA, Tanabe KK, Ott MJ, Souba WW (1999) Surgical management of phyllodes tumors. Arch Surg 134:487–493PubMed Mangi AA, Smith BL, Gadd MA, Tanabe KK, Ott MJ, Souba WW (1999) Surgical management of phyllodes tumors. Arch Surg 134:487–493PubMed
15.
Zurück zum Zitat Kapiris I, Nasiri N, A'Hern R, Healy V, Gui GPH (2001) Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumours of the breast. Eur J Surg Oncol 27:723–730PubMed Kapiris I, Nasiri N, A'Hern R, Healy V, Gui GPH (2001) Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumours of the breast. Eur J Surg Oncol 27:723–730PubMed
16.
Zurück zum Zitat Grimes MM (1992) Cystosarcoma phyllodes of the breast: histologic features, flow cytometric analysis, and clinical correlations. Mod Pathol 5:232–239PubMed Grimes MM (1992) Cystosarcoma phyllodes of the breast: histologic features, flow cytometric analysis, and clinical correlations. Mod Pathol 5:232–239PubMed
17.
Zurück zum Zitat Chua CL, Thomas A, Ng BK (1989) Cystosarcoma phyllodes: a review of surgical options. Surgery 105:141–147PubMed Chua CL, Thomas A, Ng BK (1989) Cystosarcoma phyllodes: a review of surgical options. Surgery 105:141–147PubMed
18.
Zurück zum Zitat Macdonald OK, Lee CM, Tward JD, Chappel CD, Gaffney DK (2006) Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. Cancer 107:2127–2133PubMed Macdonald OK, Lee CM, Tward JD, Chappel CD, Gaffney DK (2006) Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. Cancer 107:2127–2133PubMed
19.
Zurück zum Zitat Joshi SC, Sharma DN, Bahadur AK, Maurya R, Kumar S, Khurana N (2003) Cystosarcoma phyllodes: our institutional experience. Australas Radiol 47:434–437PubMed Joshi SC, Sharma DN, Bahadur AK, Maurya R, Kumar S, Khurana N (2003) Cystosarcoma phyllodes: our institutional experience. Australas Radiol 47:434–437PubMed
20.
Zurück zum Zitat Bhargav PRK, Mishra A, Agarwal G, Agarwal A, Verma AK, Mishra SK (2009) Phyllodes Tumour of the Breast: Clinicopathological Analysis of Recurrent vs. Non-recurrent Cases Asian J Surg 32:224–228PubMed Bhargav PRK, Mishra A, Agarwal G, Agarwal A, Verma AK, Mishra SK (2009) Phyllodes Tumour of the Breast: Clinicopathological Analysis of Recurrent vs. Non-recurrent Cases Asian J Surg 32:224–228PubMed
21.
Zurück zum Zitat Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE et al (2000) Primary treatment of cystosarcoma phyllodes of the breast. Cancer 89:1502–1511PubMed Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE et al (2000) Primary treatment of cystosarcoma phyllodes of the breast. Cancer 89:1502–1511PubMed
22.
Zurück zum Zitat Barth RJ Jr, Wells WA, Mitchell SE, Cole BF (2009) A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors. Ann Surg Oncol 16:2288–2294PubMedPubMedCentral Barth RJ Jr, Wells WA, Mitchell SE, Cole BF (2009) A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors. Ann Surg Oncol 16:2288–2294PubMedPubMedCentral
23.
Zurück zum Zitat Geisler DP, Boyle MJ, Malnar KF, McGee JM, Nolen MC, Fortner SM et al (2000) Phyllodes tumors of the breast: a review of 32 cases. American Surg 66:360–366 Geisler DP, Boyle MJ, Malnar KF, McGee JM, Nolen MC, Fortner SM et al (2000) Phyllodes tumors of the breast: a review of 32 cases. American Surg 66:360–366
24.
Zurück zum Zitat Abdalla HM, Sakr MA (2006) Predictive factors of local recurrence and survival following primary surgical treatment of phyllodes tumors of the breast. J Egypt Natl Canc Inst 18:125–133PubMed Abdalla HM, Sakr MA (2006) Predictive factors of local recurrence and survival following primary surgical treatment of phyllodes tumors of the breast. J Egypt Natl Canc Inst 18:125–133PubMed
25.
Zurück zum Zitat Barrio AV, Clark BD, Goldberg JI, Hoque LW, Bernik SF, Flynn LW et al (2007) Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol 14:2961–2970PubMed Barrio AV, Clark BD, Goldberg JI, Hoque LW, Bernik SF, Flynn LW et al (2007) Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol 14:2961–2970PubMed
26.
Zurück zum Zitat Belkacémi Y, Bousquet G, Marsiglia H, Ray-Coquard I, Magné N, Malard Y et al (2008) Phyllodes Tumor of the Breast. Int J Radiat Oncol Biol Phys 70:492–500PubMed Belkacémi Y, Bousquet G, Marsiglia H, Ray-Coquard I, Magné N, Malard Y et al (2008) Phyllodes Tumor of the Breast. Int J Radiat Oncol Biol Phys 70:492–500PubMed
28.
Zurück zum Zitat Tremblay-LeMay R, Hogue JC, Provencher L, Poirier B, Poirier É, Laberge S et al (2017) How Wide Should Margins Be for Phyllodes Tumors of the Breast? Breast J 23:315–322PubMed Tremblay-LeMay R, Hogue JC, Provencher L, Poirier B, Poirier É, Laberge S et al (2017) How Wide Should Margins Be for Phyllodes Tumors of the Breast? Breast J 23:315–322PubMed
29.
Zurück zum Zitat Yom CK, Han W, Kim SW, Park SY, Park IA, Noh DY (2015) Reappraisal of conventional risk stratification for local recurrence based on clinical outcomes in 285 resected phyllodes tumors of the breast. Ann Surg Oncol 22:2912–2918PubMed Yom CK, Han W, Kim SW, Park SY, Park IA, Noh DY (2015) Reappraisal of conventional risk stratification for local recurrence based on clinical outcomes in 285 resected phyllodes tumors of the breast. Ann Surg Oncol 22:2912–2918PubMed
30.
Zurück zum Zitat Lenhard MS, Kahlert S, Himsl I, Ditsch N, Untch M, Bauerfeind I (2008) Phyllodes tumour of the breast: Clinical follow-up of 33 cases of this rare disease. Eur J Obstet Gynecol Reprod Biol 138:217–221PubMed Lenhard MS, Kahlert S, Himsl I, Ditsch N, Untch M, Bauerfeind I (2008) Phyllodes tumour of the breast: Clinical follow-up of 33 cases of this rare disease. Eur J Obstet Gynecol Reprod Biol 138:217–221PubMed
31.
Zurück zum Zitat Jang JH, Choi MY, Lee SK, Kim S, Kim J, Lee J et al (2012) Clinicopathologic risk factors for the local recurrence of phyllodes tumors of the breast. Ann Surg Oncol 19:2612–2617PubMed Jang JH, Choi MY, Lee SK, Kim S, Kim J, Lee J et al (2012) Clinicopathologic risk factors for the local recurrence of phyllodes tumors of the breast. Ann Surg Oncol 19:2612–2617PubMed
32.
Zurück zum Zitat Lin CC, Chang HW, Lin CY, Chiu CF, Yeh SP (2013) The clinical features and prognosis of phyllodes tumors: A single institution experience in Taiwan. Int J Clin Oncol 18:614–620PubMed Lin CC, Chang HW, Lin CY, Chiu CF, Yeh SP (2013) The clinical features and prognosis of phyllodes tumors: A single institution experience in Taiwan. Int J Clin Oncol 18:614–620PubMed
33.
Zurück zum Zitat Sawalhi S, Al-Shatti M (2013) Phyllodes tumor of the breast: a retrospective study of the impact of histopathological factors in local recurrence and distant metastasis. Ann Saudi Med 33:162–168PubMedPubMedCentral Sawalhi S, Al-Shatti M (2013) Phyllodes tumor of the breast: a retrospective study of the impact of histopathological factors in local recurrence and distant metastasis. Ann Saudi Med 33:162–168PubMedPubMedCentral
34.
Zurück zum Zitat Taira N, Takabatake D, Aogi K, Ohsumi S, Takashima S, Nishimura R et al (2007) Phyllodes tumor of the breast: Stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin. Jpn J Clin Oncol 37:730–736PubMed Taira N, Takabatake D, Aogi K, Ohsumi S, Takashima S, Nishimura R et al (2007) Phyllodes tumor of the breast: Stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin. Jpn J Clin Oncol 37:730–736PubMed
35.
Zurück zum Zitat Cheng SP, Chang YC, Liu TP, Lee JJ, Tzen CY, Liu CL (2006) Phyllodes tumor of the breast: The challenge persists. World J Surg 30:1414–1421PubMed Cheng SP, Chang YC, Liu TP, Lee JJ, Tzen CY, Liu CL (2006) Phyllodes tumor of the breast: The challenge persists. World J Surg 30:1414–1421PubMed
36.
Zurück zum Zitat Esposito NN, Mohan D, Brufsky A, Lin Y, Kapali M, Dabbs DJ (2006) Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases. Arch Pathol Lab Med 130:1516–1521PubMed Esposito NN, Mohan D, Brufsky A, Lin Y, Kapali M, Dabbs DJ (2006) Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases. Arch Pathol Lab Med 130:1516–1521PubMed
37.
Zurück zum Zitat Karim RZ, Gerega SK, Yang YH, Spillane A, Carmalt H, Scolyer RA et al (2009) Phyllodes tumours of the breast: A clinicopathological analysis of 65 cases from a single institution. The Breast 18:165–170PubMed Karim RZ, Gerega SK, Yang YH, Spillane A, Carmalt H, Scolyer RA et al (2009) Phyllodes tumours of the breast: A clinicopathological analysis of 65 cases from a single institution. The Breast 18:165–170PubMed
38.
Zurück zum Zitat Chng TW, Lee JYH, Lee CS, Li H, Tan MH, Tan PH (2016) Validation of the Singapore nomogram for outcome prediction in breast phyllodes tumours: An Australian cohort. J Clinic Pathol 69:1124–1126 Chng TW, Lee JYH, Lee CS, Li H, Tan MH, Tan PH (2016) Validation of the Singapore nomogram for outcome prediction in breast phyllodes tumours: An Australian cohort. J Clinic Pathol 69:1124–1126
39.
Zurück zum Zitat Shaaban M, Barthelmes L (2017) Benign phyllodes tumours of the breast: (Over) treatment of margins – A literature review. Eur J Surg Oncol 43:1186–1190PubMed Shaaban M, Barthelmes L (2017) Benign phyllodes tumours of the breast: (Over) treatment of margins – A literature review. Eur J Surg Oncol 43:1186–1190PubMed
40.
Zurück zum Zitat Spitaleri G, Toesca A, Botteri E, Bottiglieri L, Rotmensz N, Boselli S et al (2013) Breast phyllodes tumor: A review of literature and a single center retrospective series analysis. Crit Rev Oncol Hematol 88:427–436PubMed Spitaleri G, Toesca A, Botteri E, Bottiglieri L, Rotmensz N, Boselli S et al (2013) Breast phyllodes tumor: A review of literature and a single center retrospective series analysis. Crit Rev Oncol Hematol 88:427–436PubMed
41.
Zurück zum Zitat Lu Y, Chen Y, Zhu L, Cartwright P, Song E, Jacobs L et al (2019) Local Recurrence of Benign, Borderline, and Malignant Phyllodes Tumors of the Breast: A Systematic Review and Meta-analysis. Ann Surg Oncol 26:1263–1275PubMed Lu Y, Chen Y, Zhu L, Cartwright P, Song E, Jacobs L et al (2019) Local Recurrence of Benign, Borderline, and Malignant Phyllodes Tumors of the Breast: A Systematic Review and Meta-analysis. Ann Surg Oncol 26:1263–1275PubMed
42.
Zurück zum Zitat Institute TJB (2014) The Joanna Briggs Institute Reviewers’ Manual 2014. The Joanna Briggs Institute, Adelaïde Institute TJB (2014) The Joanna Briggs Institute Reviewers’ Manual 2014. The Joanna Briggs Institute, Adelaïde
43.
44.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097PubMedPubMedCentral Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097PubMedPubMedCentral
45.
Zurück zum Zitat Institute TJB (2016) The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews. The Joanna Briggs Institute, Checklist for Case Series. Adelaïde Institute TJB (2016) The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews. The Joanna Briggs Institute, Checklist for Case Series. Adelaïde
46.
Zurück zum Zitat Piaget-Rossel R, Taffe P. Meta-analysis of rare events under the assumption of a homogeneous treatment effect. Biom J 2019. Piaget-Rossel R, Taffe P. Meta-analysis of rare events under the assumption of a homogeneous treatment effect. Biom J 2019.
47.
Zurück zum Zitat Huang C-C, Liu T-P, Cheng S-P, Chang Y-C (2014) Surgical Treatment of Phyllodes Tumor of the Breast with the Trend. J Exp Clin Med 6:161–165 Huang C-C, Liu T-P, Cheng S-P, Chang Y-C (2014) Surgical Treatment of Phyllodes Tumor of the Breast with the Trend. J Exp Clin Med 6:161–165
48.
Zurück zum Zitat Chen WH, Cheng SP, Tzen CY, Yang TL, Jeng KS, Liu CL et al (2005) Surgical treatment of phyllodes tumors of the breast: Retrospective review of 172 cases. J Surg Oncol 91:185–194PubMed Chen WH, Cheng SP, Tzen CY, Yang TL, Jeng KS, Liu CL et al (2005) Surgical treatment of phyllodes tumors of the breast: Retrospective review of 172 cases. J Surg Oncol 91:185–194PubMed
49.
Zurück zum Zitat Ruvalcaba-Limon E, Jimenez-Lopez J, Bautista-Pina V, Ramirez-Bollas J, Morales-Vasquez F, Dominguez-Reyes A et al (2016) Phyllodes tumor of the breast : 307 treatede cases, the largest Mexican experience at a single breast disease institution. Iran J Pathol 11:399–408PubMedPubMedCentral Ruvalcaba-Limon E, Jimenez-Lopez J, Bautista-Pina V, Ramirez-Bollas J, Morales-Vasquez F, Dominguez-Reyes A et al (2016) Phyllodes tumor of the breast : 307 treatede cases, the largest Mexican experience at a single breast disease institution. Iran J Pathol 11:399–408PubMedPubMedCentral
50.
Zurück zum Zitat Brenes JM, Furió V, Moreno MA, Merchán MJ, Ruiz J, Olivares ME et al (2013) Manejo clínico, tratamiento y control local del tumor phyllodes mamario. Rev Senol Patol Mamar 26:52–57 Brenes JM, Furió V, Moreno MA, Merchán MJ, Ruiz J, Olivares ME et al (2013) Manejo clínico, tratamiento y control local del tumor phyllodes mamario. Rev Senol Patol Mamar 26:52–57
51.
Zurück zum Zitat Moutte A, Chopin N, Faure C, Beurrier F, Quoc CH, Guinaudeau F et al (2016) Surgical management of benign and borderline phyllodes tumors of the breast. Breast J 22(5):547–552PubMed Moutte A, Chopin N, Faure C, Beurrier F, Quoc CH, Guinaudeau F et al (2016) Surgical management of benign and borderline phyllodes tumors of the breast. Breast J 22(5):547–552PubMed
52.
Zurück zum Zitat Abdul Hamid S, Rahmat K, Ramli MT, Fadzli F, Jamaris S, See MH et al (2018) Radiopathological characteristics and outcomes of phyllodes tumor of the breast in Malaysian women. Medicine 97:e11412PubMedPubMedCentral Abdul Hamid S, Rahmat K, Ramli MT, Fadzli F, Jamaris S, See MH et al (2018) Radiopathological characteristics and outcomes of phyllodes tumor of the breast in Malaysian women. Medicine 97:e11412PubMedPubMedCentral
53.
Zurück zum Zitat Mitus JW, Blecharz P, Jakubowicz J, Reinfuss M, Walasek T, Wysocki W (2019) Phyllodes tumors of the breast The treatment results for 340 patients from a single cancer centre. Breast 43:85–90PubMed Mitus JW, Blecharz P, Jakubowicz J, Reinfuss M, Walasek T, Wysocki W (2019) Phyllodes tumors of the breast The treatment results for 340 patients from a single cancer centre. Breast 43:85–90PubMed
54.
Zurück zum Zitat Akin M, Irkorucu O, Koksal H, Gonul II, Gultekin S, Kurukahvecioglu O et al (2010) Phyllodes tumor of the breast; a case series. Bratisl Lek Listy 111:271–274PubMed Akin M, Irkorucu O, Koksal H, Gonul II, Gultekin S, Kurukahvecioglu O et al (2010) Phyllodes tumor of the breast; a case series. Bratisl Lek Listy 111:271–274PubMed
55.
Zurück zum Zitat Sevinc AI, Aksoy SO, Guray Durak M, Balci P (2018) Is the extent of surgical resection important in patient outcome in benign and borderline phyllodes tumors of the breast? Turk J Med Sci 48:28–33PubMed Sevinc AI, Aksoy SO, Guray Durak M, Balci P (2018) Is the extent of surgical resection important in patient outcome in benign and borderline phyllodes tumors of the breast? Turk J Med Sci 48:28–33PubMed
56.
Zurück zum Zitat Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13PubMedPubMedCentral Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13PubMedPubMedCentral
57.
Zurück zum Zitat Mituś J, Reinfuss M, Mituś JW, Jakubowicz J, Blecharz P, Wysocki WM et al (2014) Malignant Phyllodes Tumor of the Breast: Treatment and Prognosis. Breast J 20:639–644PubMed Mituś J, Reinfuss M, Mituś JW, Jakubowicz J, Blecharz P, Wysocki WM et al (2014) Malignant Phyllodes Tumor of the Breast: Treatment and Prognosis. Breast J 20:639–644PubMed
58.
Zurück zum Zitat Salvadori B, Cusumano F, Del Bo R, Delledonne V, Grassi M, Rovini D et al (1989) Surgical treatment of phyllodes tumors of the breast. Cancer 63:2532–2536PubMed Salvadori B, Cusumano F, Del Bo R, Delledonne V, Grassi M, Rovini D et al (1989) Surgical treatment of phyllodes tumors of the breast. Cancer 63:2532–2536PubMed
59.
Zurück zum Zitat Tan PH, Thike AA, Tan WJ, Thu MMM, Busmanis I, Li H et al (2012) Predicting clinical behaviour of breast phyllodes tumours: A nomogram based on histological criteria and surgical margins. J Clin Pathol 65:69–76PubMed Tan PH, Thike AA, Tan WJ, Thu MMM, Busmanis I, Li H et al (2012) Predicting clinical behaviour of breast phyllodes tumours: A nomogram based on histological criteria and surgical margins. J Clin Pathol 65:69–76PubMed
60.
Zurück zum Zitat Akrami M, Tahmasebi S, Talei A, Abdollahi A, Hosseini S, Namazi M (2015) Clinical outcome of patients with breast phyllodes tumors: a retrospective analysis of 129 cases in shiraz. Southern Iran Middle East J Cancer 6:267–273 Akrami M, Tahmasebi S, Talei A, Abdollahi A, Hosseini S, Namazi M (2015) Clinical outcome of patients with breast phyllodes tumors: a retrospective analysis of 129 cases in shiraz. Southern Iran Middle East J Cancer 6:267–273
61.
Zurück zum Zitat Narayanakar RP, Gangaiah DM, Althaf S, Dev K, Kurpad V, Gurawalia J (2015) Cystosarcoma phyllodes: Pathological enigma: A retrospective review of 162 cases. Indian J Cancer 52:365–368PubMed Narayanakar RP, Gangaiah DM, Althaf S, Dev K, Kurpad V, Gurawalia J (2015) Cystosarcoma phyllodes: Pathological enigma: A retrospective review of 162 cases. Indian J Cancer 52:365–368PubMed
62.
Zurück zum Zitat Sotheran W, Domjan J, Jeffrey M, Wise MH, Perry PM (2005) Phyllodes tumours of the breast–a retrospective study from 1982–2000 of 50 cases in Portsmouth. Ann R Coll Surg Engl 87:339–344PubMedPubMedCentral Sotheran W, Domjan J, Jeffrey M, Wise MH, Perry PM (2005) Phyllodes tumours of the breast–a retrospective study from 1982–2000 of 50 cases in Portsmouth. Ann R Coll Surg Engl 87:339–344PubMedPubMedCentral
63.
Zurück zum Zitat Varghese SS, Sasidharan B, Manipadam MT, Paul MJ, Backianathan S (2017) Radiotherapy in Phyllodes Tumour. J Clin Diagn Res 11:Xc01–Xc3PubMedPubMedCentral Varghese SS, Sasidharan B, Manipadam MT, Paul MJ, Backianathan S (2017) Radiotherapy in Phyllodes Tumour. J Clin Diagn Res 11:Xc01–Xc3PubMedPubMedCentral
64.
Zurück zum Zitat Zurrida S, Galimberti V, Bartoli C, de Palo G, Squicciarini P, Delledonne V et al (1992) Which therapy for unexpected phyllode tumour of the breast? Eur J Cancer 28:654–657PubMed Zurrida S, Galimberti V, Bartoli C, de Palo G, Squicciarini P, Delledonne V et al (1992) Which therapy for unexpected phyllode tumour of the breast? Eur J Cancer 28:654–657PubMed
65.
Zurück zum Zitat Moo TA, Alabdulkareem H, Tam A, Fontanet C, Lu Y, Landers A et al (2017) Association Between Recurrence and Re-Excision for Close and Positive Margins Versus Observation in Patients with Benign Phyllodes Tumors. Ann Surg Oncol 24:3088–3092PubMed Moo TA, Alabdulkareem H, Tam A, Fontanet C, Lu Y, Landers A et al (2017) Association Between Recurrence and Re-Excision for Close and Positive Margins Versus Observation in Patients with Benign Phyllodes Tumors. Ann Surg Oncol 24:3088–3092PubMed
66.
Zurück zum Zitat Haberer S, Laé M, Seegers V, Pierga JY, Salmon R, Kirova YM et al (2009) Prise en charge des tumeurs phyllodes malignes du sein : l’expérience de l’institut Curie. Cancer/Radiothérapie 13:305–312 Haberer S, Laé M, Seegers V, Pierga JY, Salmon R, Kirova YM et al (2009) Prise en charge des tumeurs phyllodes malignes du sein : l’expérience de l’institut Curie. Cancer/Radiothérapie 13:305–312
67.
Zurück zum Zitat Onkendi EO, Jimenez RE, Spears GM, Harmsen WS, Ballman KV, Hieken TJ (2014) Surgical treatment of borderline and malignant phyllodes tumors: The effect of the extent of resection and tumor characteristics on patient outcomes. Ann Surg Oncol 21:93–94 Onkendi EO, Jimenez RE, Spears GM, Harmsen WS, Ballman KV, Hieken TJ (2014) Surgical treatment of borderline and malignant phyllodes tumors: The effect of the extent of resection and tumor characteristics on patient outcomes. Ann Surg Oncol 21:93–94
68.
Zurück zum Zitat Adam MJ, Bendifallah S, Kalhorpour N, Cohen-Steiner C, Ropars L, Mahmood A et al (2018) Time to revise classification of phyllodes tumors of breast? Results of a French multicentric study. Eur J Surg Oncol 44:1743–1749PubMed Adam MJ, Bendifallah S, Kalhorpour N, Cohen-Steiner C, Ropars L, Mahmood A et al (2018) Time to revise classification of phyllodes tumors of breast? Results of a French multicentric study. Eur J Surg Oncol 44:1743–1749PubMed
69.
Zurück zum Zitat Fou A, Schnabel FR, Hamele-Bena D, Wei X-J, Cheng B, El Tamer M et al (2006) Long-term outcomes of malignant phyllodes tumors patients: an institutional experience. Am J Surg 192:492–495PubMed Fou A, Schnabel FR, Hamele-Bena D, Wei X-J, Cheng B, El Tamer M et al (2006) Long-term outcomes of malignant phyllodes tumors patients: an institutional experience. Am J Surg 192:492–495PubMed
70.
Zurück zum Zitat Stockdale AD, Leader M (1987) Phyllodes tumour of the breast: response to radiotherapy. Clin Radiol 38:287PubMed Stockdale AD, Leader M (1987) Phyllodes tumour of the breast: response to radiotherapy. Clin Radiol 38:287PubMed
71.
Zurück zum Zitat Piaget-Rossel R, Taffe P (2019) Meta-analysis of incidence rate data in the presence of zero-event and sigle-arm studies. Res Synth Methods 61(6):1557–1574 Piaget-Rossel R, Taffe P (2019) Meta-analysis of incidence rate data in the presence of zero-event and sigle-arm studies. Res Synth Methods 61(6):1557–1574
Metadaten
Titel
Width of margins in phyllodes tumors of the breast: the controversy drags on?—a systematic review and meta-analysis
verfasst von
Arnaud Toussaint
Romain Piaget-Rossel
Coraline Stormacq
Patrice Mathevet
Karine Lepigeon
Patrick Taffé
Publikationsdatum
15.09.2020
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2021
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-020-05924-8

Weitere Artikel der Ausgabe 1/2021

Breast Cancer Research and Treatment 1/2021 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.